J-code: Drugs administered other than oral method; chemotherapy drugs Drugs administered other than oral method; chemotherapy drugs
1,255 codes
Billing context
J-codes are permanent national codes for drugs and biologicals — most often clinician-administered (buy-and-bill) products paid under Medicare Part B — plus certain immunosuppressive, inhalation (via DME), and oral anticancer/antiemetic drugs. Units are reported in multiples of the dosage in the code descriptor.
| Code | Long descriptor | Payment limit (Q4 2026) | Added | Status |
|---|---|---|---|---|
| J1961 | Injection, lenacapavir (only for use as hiv treatment), 1 mg | $22.937per 1 MG | Jul 1, 2023 | Active |
| J1980 | Injection, hyoscyamine sulfate, up to 0.25 mg | — | Jan 1, 1982 | Active |
| J1990 | Injection, chlordiazepoxide hcl, up to 100 mg | — | Jan 1, 1982 | Active |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | — | Jan 1, 2004 | Ended Sep 30, 2024 |
| J2002 | Injection, lidocaine hcl in 5% dextrose, 1 mg | $0.003per 1 MG | Oct 1, 2024 | Active |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | — | Oct 1, 2024 | Active |
| J2004 | Injection, lidocaine hcl with epinephrine, 1 mg | — | Oct 1, 2024 | Active |
| J2010 | Injection, lincomycin hcl, up to 300 mg | $3.690per 300 MG | Jan 1, 1982 | Active |
| J2020 | Injection, linezolid, 200 mg | $2.431per 200 MG | Jan 1, 2002 | Active |
| J2021 | Injection, linezolid (hospira), not therapeutically equivalent to j2020, 200 mg | $31.611per 200 MG | Jan 1, 2023 | Active |
| J2060 | Injection, lorazepam, 2 mg | $2.197per 2 MG | Jan 1, 1982 | Active |
| J2062 | Loxapine for inhalation, 1 mg | — | Jan 1, 2019 | Active |
| J2150 | Injection, mannitol, 25% in 50 ml | — | Jan 1, 1986 | Ended Sep 30, 2025 |
| J2151 | Injection, mannitol, 250 mg | $0.112per 250 MG | Oct 1, 2025 | Active |
| J2170 | Injection, mecasermin, 1 mg | — | Jan 1, 2007 | Active |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | $9.652per 100 MG | Jan 1, 1986 | Active |
| J2180 | Injection, meperidine and promethazine hcl, up to 50 mg | — | Jan 1, 1982 | Active |
| J2182 | Injection, mepolizumab, 1 mg | $32.181per 1 MG | Jan 1, 2017 | Active |
| J2183 | Injection, meropenem (wg critical care), not therapeutically equivalent to j2185, 100 mg | $1.339per 100 MG | Jul 1, 2024 | Active |
| J2184 | Injection, meropenem (b. braun), not therapeutically equivalent to j2185, 100 mg | $1.921per 100 MG | Jan 1, 2023 | Active |
| J2185 | Injection, meropenem, 100 mg | $0.358per 100 MG | Jan 1, 2004 | Active |
| J2186 | Injection, meropenem and vaborbactam, 10mg/10mg (20mg) | — | Jan 1, 2019 | Active |
| J2210 | Injection, methylergonovine maleate, up to 0.2 mg | $22.117per 0.2 MG | Jan 1, 1982 | Active |
| J2212 | Injection, methylnaltrexone, 0.1 mg | — | Jan 1, 2013 | Active |
| J2246 | Injection, micafungin in sodium (baxter), not therapeutically equivalent to j2248, 1 mg | $0.334per 1 MG | Jul 1, 2024 | Active |
| J2247 | Injection, micafungin sodium (par pharm) not thereapeutically equivalent to j2248, 1 mg | $0.219per 1 MG | Jan 1, 2023 | Active |
| J2248 | Injection, micafungin sodium, 1 mg | $0.203per 1 MG | Jan 1, 2007 | Active |
| J2249 | Injection, remimazolam, 1 mg | — | Jul 1, 2023 | Active |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | $0.167per 1 MG | Jan 1, 1996 | Active |
| J2251 | Injection, midazolam in 0.9% sodium chloride, intravenous, not therapeutically equivalent to j2250, 1 mg | $0.078per 1 MG | Jan 1, 2023 | Active |
| J2252 | Injection, midazolam in 0.8% sodium chloride, intravenous, not therapeutically equivalent to j2250, 1 mg | — | Oct 1, 2024 | Active |
| J2253 | Injection, midazolam (seizalam), 1 mg | — | Oct 1, 2024 | Active |
| J2260 | Injection, milrinone lactate, 5 mg | $1.143per 5 MG | Jan 1, 1986 | Active |
| J2265 | Injection, minocycline hydrochloride, 1 mg | — | Jan 1, 2012 | Active |
| J2267 | Injection, mirikizumab-mrkz, 1 mg | $32.584per 1 MG | Jul 1, 2024 | Active |
| J2270 | Injection, morphine sulfate, up to 10 mg | $7.259per 10 MG | Jan 1, 1982 | Active |
| J2271 | Injection, morphine sulfate, 100mg | — | Jan 1, 1999 | Ended Dec 31, 2014 |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | $9.406per 10 MG | Jan 1, 2023 | Active |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | $16.044per 10 MG | Jan 1, 2015 | Active |
| J2275 | Injection, morphine sulfate (preservative-free sterile solution), per 10 mg | — | Jan 1, 1993 | Ended Dec 31, 2014 |
| J2277 | Injection, motixafortide, 0.25 mg | $26.479per 0.25 MG | Apr 1, 2024 | Active |
| J2278 | Injection, ziconotide, 1 microgram | $10.656per 1 MCG | Jan 1, 2006 | Active |
| J2280 | Injection, moxifloxacin, 100 mg | $8.744per 100 MG | Jan 1, 2004 | Active |
| J2281 | Injection, moxifloxacin (fresenius kabi), not therapeutically equivalent to j2280, 100 mg | $6.641per 100 MG | Jan 1, 2023 | Active |
| J2290 | Injection, nafcillin sodium, 20 mg | $0.047per 20 MG | Jan 1, 2025 | Active |
| J2291 | Injection, nafcillin sodium (baxter), 20 mg | $0.135per 20 MG | Oct 1, 2025 | Active |
| J2300 | Injection, nalbuphine hydrochloride, per 10 mg | $4.071per 10 MG | Jan 1, 1996 | Active |
| J2305 | Injection, nitroglycerin, 5 mg | $1.542per 5 MG | Jul 1, 2023 | Active |
| J2310 | Injection, naloxone hydrochloride, per 1 mg | — | Jan 1, 1996 | Ended Jun 30, 2025 |
| J2311 | Injection, naloxone hydrochloride (zimhi), 1 mg | — | Jan 1, 2023 | Ended Jun 30, 2025 |
| J2312 | Injection, naloxone hydrochloride, not otherwise specified, 0.01 mgNOC / NOS | $0.076per 0.01 MG | Jul 1, 2025 | Active |
| J2313 | Injection, naloxone hydrochloride (zimhi), 0.01 mg | — | Jul 1, 2025 | Active |
| J2315 | Injection, naltrexone, depot form, 1 mg | $4.537per 1 MG | Jan 1, 2007 | Active |
| J2320 | Injection, nandrolone decanoate, up to 50 mg | — | Jan 1, 1986 | Active |
| J2323 | Injection, natalizumab, 1 mg | $23.927per 1 MG | Jan 1, 2008 | Active |
| J2325 | Injection, nesiritide, 0.1 mg | — | Jan 1, 2006 | Active |
| J2326 | Injection, nusinersen, 0.1 mg | — | Jan 1, 2018 | Active |
| J2327 | Injection, risankizumab-rzaa, intravenous, 1 mg | $14.011per 1 MG | Jan 1, 2023 | Active |
| J2329 | Injection, ublituximab-xiiy, 1mg | $71.089per 1 MG | Jul 1, 2023 | Active |
| J2350 | Injection, ocrelizumab, 1 mg | $60.689per 1 MG | Jan 1, 2018 | Active |
| J2351 | Injection, ocrelizumab, 1 mg and hyaluronidase-ocsq | $47.287per 1 MG | Apr 1, 2025 | Active |
| J2353 | Injection, octreotide, depot form for intramuscular injection, 1 mg | $211.321per 1 MG | Jan 1, 2004 | Active |
| J2354 | Injection, octreotide, non-depot form for subcutaneous or intravenous injection, 25 mcg | $0.574per 25 MCG | Jan 1, 2004 | Active |
| J2355 | Injection, oprelvekin, 5 mg | — | Jan 1, 1999 | Active |
| J2356 | Injection, tezepelumab-ekko, 1 mg | $17.839per 1 MG | Jul 1, 2022 | Active |
| J2357 | Injection, omalizumab, 5 mg | $45.687per 5 MG | Jan 1, 2005 | Active |
| J2358 | Injection, olanzapine, long-acting, 1 mg | $3.202per 1 MG | Jan 1, 2011 | Active |
| J2359 | Injection, olanzapine, 0.5 mg | $0.615per 0.5 MG | Oct 1, 2023 | Active |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | $6.274per 60 MG | Jan 1, 1982 | Active |
| J2361 | Injection, depemokimab-ulaa, 1 mg | $275.391per 1 MG | Jul 1, 2026 | Active |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | — | Jan 1, 1982 | Ended Jun 30, 2023 |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | $0.002per 20 MCG | Jul 1, 2023 | Active |
| J2372 | Injection, phenylephrine hydrochloride (biorphen), 20 micrograms | $0.162per 20 MCG | Jul 1, 2023 | Active |
| J2373 | Injection, phenylephrine hydrochloride (immphentiv), 20 micrograms | $0.136per 20 MCG | Jul 1, 2024 | Active |
| J2374 | Apraclonidine hydrochloride ophthalmic, 1% solution, 0.1 ml | $28.804per 0.1 ML | Jul 1, 2026 | Active |
| J2400 | Injection, chloroprocaine hydrochloride, per 30 ml | — | Jan 1, 1986 | Ended Dec 31, 2022 |
| J2401 | Injection, chloroprocaine hydrochloride, per 1 mg | $0.045per 1 MG | Jan 1, 2023 | Active |
| J2402 | Injection, chloroprocaine hydrochloride (clorotekal), per 1 mg | — | Jan 1, 2023 | Active |
| J2403 | Chloroprocaine hcl ophthalmic, 3% gel, 1 mg | $0.721per 1 MG | Apr 1, 2023 | Active |
| J2404 | Injection, nicardipine, 0.1 mg | $0.057per 0.1 MG | Jan 1, 2024 | Active |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | $0.084per 1 MG | Jan 1, 1993 | Active |
| J2406 | Injection, oritavancin (kimyrsa), 10 mg | $44.392per 10 MG | Oct 1, 2021 | Active |
| J2407 | Injection, oritavancin (orbactiv), 10 mg | $29.811per 10 MG | Jan 1, 2016 | Active |
| J2410 | Injection, oxymorphone hcl, up to 1 mg | — | Jan 1, 1982 | Active |
| J2425 | Injection, palifermin, 50 micrograms | $38.839per 50 MCG | Jan 1, 2006 | Active |
| J2426 | Injection, paliperidone palmitate extended release (invega sustenna), 1 mg | $15.437per 1 MG | Jan 1, 2011 | Active |
| J2427 | Injection, paliperidone palmitate extended release (invega hafyera, or invega trinza), 1 mg | $13.246per 1MG | Jul 1, 2023 | Active |
| J2428 | Injection, paliperidone palmitate extended release (erzofri), 1 mg | $15.587per 1 MG | Apr 1, 2025 | Active |
| J2430 | Injection, pamidronate disodium, per 30 mg | $11.306per 30 MG | Jan 1, 1982 | Active |
| J2440 | Injection, papaverine hcl, up to 60 mg | — | Jan 1, 1986 | Active |
| J2460 | Injection, oxytetracycline hcl, up to 50 mg | — | Jan 1, 1982 | Active |
| J2468 | Injection, palonosetron hydrochloride (posfrea), 25 micrograms | $54.086per 25 MCG | Jul 1, 2024 | Active |
| J2469 | Injection, palonosetron hcl, 25 mcg | $0.469per 25 MCG | Jan 1, 2005 | Active |
| J2470 | Injection, pantoprazole sodium, 40 mg | — | Jul 1, 2024 | Active |
| J2471 | Injection, pantoprazole (hikma), not therapeutically equivalent to j2470, 40 mg | — | Jul 1, 2024 | Active |
| J2472 | Injection, pantoprazole sodium in sodium chloride (baxter), 40 mg | — | Jan 1, 2025 | Active |
| J2501 | Injection, paricalcitol, 1 mcg | $0.891per 1 MCG | Jan 1, 2003 | Active |
| J2502 | Injection, pasireotide long acting, 1 mg | $613.140per 1 MG | Jan 1, 2016 | Active |
| J2503 | Injection, pegaptanib sodium, 0.3 mg | — | Jan 1, 2006 | Ended Sep 30, 2025 |
| J2504 | Injection, pegademase bovine, 25 iu | — | Jan 1, 2006 | Ended Dec 31, 2025 |